Cancer registry for people living in a specific French region
Part of Cancer clinical trials.
This study helps build a population-wide cancer observatory (a real-world cancer record) for people in a specific region of France. It may help researchers better understand cancer patterns and needs in the area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer (invasive or early/non-invasive).
- You currently live in the French region Sud-Provence-Alpes-Côte d'Azur (Region Sud).
- You may be included even if your cancer is still early (in situ) or more advanced (invasive).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who take oral anticancer drugs and take part in a special monitoring program at Lyon-Sud hospital. It aims to understand what affects treatment safety and outcomes.
This study collects medical information and small tissue or fluid samples from people with peritoneal (abdominal lining) cancer. It aims to better understand the disease and improve future care plans.
This study pairs people newly diagnosed or living with cancer with trained peer advisors who have had cancer themselves. Together they talk and support each other through the experience.
This trial is a real-world registry that collects information during follow-up for certain early-stage bladder cancer. It may help doctors understand how urinary test results relate to recurrence and guide monitoring over time.
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
This is a hospital-based study that builds a clinical and biological database for people treated for rectal cancer at the Montpellier Cancer Institute. It helps researchers organize health information to better understand rectal cancer and improve future care.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.